Business Context and Reporting Period
Company: Starry Sea Acquisition Corp (SSEA)
Filing Type: Form 8-K (Current Report)
Date of Report: September 29, 2025
Event: Entry into a Material Definitive Agreement (Letter of Intent) for a proposed business combination with Forever Young International Limited, a Cayman Islands exempted company providing medical institution management services in China.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain audited financial statements, revenue, profit, cash flow, or margin data for the reporting period.
- Proposed Pre-Money Equity Value: Approximately USD 750 million to USD 900 million (subject to due diligence).
- Consideration Structure: Expected to be comprised of rollover equity to Forever Young shareholders in the form of ordinary shares of the post-closing entity.
- Share Valuation Assumption: Ordinary shares valued at $10 per share for consideration calculation.
- Debt and Liquidity: The filing text does not provide a clear value for current debt levels or liquidity positions.
Material Changes
The primary material change is the initiation of an exclusive negotiation period for a potential merger.
- Exclusivity: The Company has agreed not to solicit, negotiate, or commit to any alternative business combination proposals while negotiating with Forever Young.
- Strategic Shift: Transition from a standalone SPAC to a potential combined entity with a health industry operator in China.
Guidance, Outlook, and Risks
Outlook: The Company anticipates entering into a definitive agreement following confirmatory due diligence. If successful, a Proxy Statement will be filed with the SEC for stockholder approval.
Risks and Contingencies:
- Transaction Uncertainty: The Letter of Intent is non-binding regarding the final terms; a definitive agreement is not guaranteed.
- Due Diligence: The proposed valuation is subject to confirmatory due diligence by both parties.
- Forward-Looking Statements: Actual results may differ materially due to the ability to satisfy closing conditions, limited operating history, competitive factors, and general economic conditions.
- Regulatory: The transaction requires stockholder approval via a Proxy Statement.
Investor Verification Checklist
- Verify the final terms of the Definitive Agreement once executed, as the current Letter of Intent is preliminary.
- Monitor the upcoming Proxy Statement for detailed financial projections and risk factors regarding Forever Young.
- Confirm the outcome of the due diligence process, which may alter the $750M-$900M valuation range.
- Review the Company's cash on hand and trust account status to ensure sufficient liquidity to complete the transaction.
- Assess the regulatory environment for cross-border mergers involving Chinese medical service providers.